Reminyl Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Galantamine HBr

Indications/Uses

Mild to moderately severe dementia of the Alzheimer type.

Click to view Reminyl detailed prescribing information

Dosage/Direction for Use

1 cap once daily in the morning.

Click to view Reminyl detailed prescribing information

Overdosage

View Reminyl overdosage for action to be taken in the event of an overdose.

Administration

Should be taken with food: Swallow whole, do not chew/crush.

Contraindications

Hypersensitivity, severe hepatic or renal disease.

Click to view Reminyl detailed prescribing information

Special Precautions

Heart disorders; stomach ulcer or history of ulcer; acute abdominal pain; epilepsy; asthma; regular wt monitoring; renal & hepatic impairment. May affect ability to drive or operate machinery. Pregnancy & lactation. Childn.

Click to view Reminyl detailed prescribing information

Use In Pregnancy & Lactation

Click to view Reminyl detailed prescribing information

Adverse Reactions

Nausea, vomiting; decreased or loss of appetite, depression; hallucinations, dizziness, headache, trembling, fatigue, drowsiness, bradycardia, high BP; diarrhea, abdominal pain & discomfort; increased sweating, muscle spasms, malaise, wt loss.

Click to view Reminyl detailed prescribing information

Drug Interactions

Other cholinomimetics, digoxin, β-blocker, succinylcholine-type muscle relaxants, CYP2D6, CYP3A4 inhibitors, ketoconazole, quinidine, paroxetine, amitriptyline, fluoxetine or fluvoxamine.

Click to view Reminyl detailed prescribing information

Description

View Reminyl description for details of the chemical structure and excipients (inactive components).

Action

View Reminyl mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Neurodegenerative Disease Drugs

ATC Classification

N06DA04 - galantamine ; Belongs to the class of anticholinesterases. Used in the management of dementia.

Regulatory Classification

POM

Presentation/Packing

Form

Reminyl PR cap 8 mg

Packing/Price

28's

Reminyl

galantamine

Manufacturer:

Janssen-Cilag

Distributor:

DKSH